Pharmacist Provided Spirometry Services: A Scoping Review.
COPD
asthma
chronic obstructive pulmonary disease
clinical pharmacy services
community pharmacy
lung disease
pulmonary function test
Journal
Integrated pharmacy research & practice
ISSN: 2230-5254
Titre abrégé: Integr Pharm Res Pract
Pays: New Zealand
ID NLM: 101656778
Informations de publication
Date de publication:
2021
2021
Historique:
received:
11
05
2021
accepted:
30
07
2021
entrez:
6
9
2021
pubmed:
7
9
2021
medline:
7
9
2021
Statut:
epublish
Résumé
Despite international guidelines' recommendations, spirometry is underutilized in the diagnosis and management of asthma and COPD. Spirometry may be an opportunity for trained pharmacists to meet the needs of patients with suspected or diagnosed lung conditions. The aim of this scoping review is to describe the literature including pharmacist provided spirometry services, specifically to identify: 1) the models of pharmacist provided spirometry services, and additional services commonly offered alongside spirometry, 2) pharmacist training and capability to obtain quality results, and (3) pharmacist, physician, and patient perspectives. In September 2020, a comprehensive literature search in PubMed and EMBASE was conducted to identify all relevant literature on the topic of pharmacist provided spirometry services using the search term: "pharmacist or pharmacy" and "spirometry or pulmonary function test or lung function test." Literature was screened using inclusion/exclusion criteria and selected articles were charted and analyzed using the themes above. A total of 27 records were included. The scoping review found that pharmacist provided spirometry has been conducted around the world in community pharmacies and clinic settings. Community pharmacists may increase access to spirometry screening; the lack of communication with primary care providers and remuneration are barriers that need to be overcome to optimize the utility of the service. Clinic-based services are interprofessional and collaborative, allowing a patient to receive the test, results, diagnosis, and medication changes in one visit. Following comprehensive training, pharmacists felt confident in their ability to perform spirometry and met quality standards at acceptable rates. Spirometry is an opportunity for pharmacists to improve evidence-based practice for screening and diagnosing lung conditions along with providing comprehensive services to complement testing. Data around provider and patient perspectives is limited and should be further investigated to determine if providers and patients would value and collaborate with pharmacists providing spirometry services.
Identifiants
pubmed: 34485107
doi: 10.2147/IPRP.S248705
pii: 248705
pmc: PMC8409516
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
93-111Informations de copyright
© 2021 Valentino et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
J Asthma. 2015;52(9):913-9
pubmed: 25563059
J Asthma. 2013 Apr;50(3):302-9
pubmed: 23270495
Prim Care Respir J. 2008 Mar;17(1):19-25
pubmed: 18322632
Tob Induc Dis. 2019 Apr 17;17:31
pubmed: 31516474
Respir Med. 2009 Jun;103(6):839-45
pubmed: 19200706
BMC Health Serv Res. 2012 Jun 18;12:164
pubmed: 22709371
Am J Respir Crit Care Med. 1995 Sep;152(3):1107-36
pubmed: 7663792
Am J Health Syst Pharm. 2009 May 15;66(10):890, 892-3
pubmed: 19420305
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88
pubmed: 31613151
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Can Respir J. 2012 Jul-Aug;19(4):249-54
pubmed: 22891184
Am J Health Syst Pharm. 2020 Sep 18;77(19):1625-1630
pubmed: 32699897
Respirology. 2004 Jun;9(2):260-4
pubmed: 15182279
JAMA. 2016 Apr 5;315(13):1372-7
pubmed: 27046365
Syst Rev. 2017 Dec 06;6(1):245
pubmed: 29208034
J Asthma. 2011 Nov;48(9):914-22
pubmed: 21942306
Panminerva Med. 2013 Mar;55(1):87-92
pubmed: 23474666
Int J Evid Based Healthc. 2015 Sep;13(3):141-6
pubmed: 26134548
Int J Pharm Pract. 2017 Oct;25(5):335-342
pubmed: 27774739
J Am Pharm Assoc (2003). 2011 Mar-Apr;51(2):203-11
pubmed: 21382811
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
Res Social Adm Pharm. 2019 Jun;15(6):662-672
pubmed: 30131254
J Prim Care Community Health. 2019 Jan-Dec;10:2150132719889715
pubmed: 31771404
J Am Pharm Assoc (2003). 2012 Sep-Oct;52(5):e59-66
pubmed: 22975798
Respir Care. 2018 Feb;63(2):242-252
pubmed: 29367384
Thorax. 2007 Jun;62(6):496-502
pubmed: 17251316
Integr Pharm Res Pract. 2017 Feb 07;6:53-59
pubmed: 29354551
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
J Am Pharm Assoc (2003). 2013 May-Jun;53(3):307-15
pubmed: 23699680
Respir Care. 2010 Mar;55(3):303-9
pubmed: 20196879
J Prim Care Community Health. 2018 Jan-Dec;9:2150132718759213
pubmed: 29468934
J Epidemiol Community Health. 2021 Apr 21;:
pubmed: 33883199
Int J Family Med. 2014;2014:962901
pubmed: 24804099
J Res Pharm Pract. 2018 Apr-Jun;7(2):88-94
pubmed: 30050962
Int J Chron Obstruct Pulmon Dis. 2013;8:389-95
pubmed: 24009418
Pharm Pract (Granada). 2011 Oct;9(4):221-7
pubmed: 24198860
Int J Clin Pharm. 2015 Oct;37(5):726-33
pubmed: 26148860
Pediatrics. 2010 Oct;126(4):682-7
pubmed: 20819894
Respir Med. 2015 Apr;109(4):475-82
pubmed: 25754101
J Asthma. 2005 Apr;42(3):163-7
pubmed: 15962871
Am J Med. 2008 Jul;121(7 Suppl):S3-12
pubmed: 18558105
Respirology. 2017 Oct;22(7):1430-1435
pubmed: 28681980
Int J Chron Obstruct Pulmon Dis. 2017 Sep 18;12:2753-2761
pubmed: 29075108
Int J Pharm Pract. 2015 Feb;23(1):83-5
pubmed: 25371146